Bioanalytical Methods

Refeyn Special Report Cover
Sponsored Content
Unlocking the Benefits of Mass Measurement: Transforming Analytical Workflows for Antibodies, Nucleic Acids, and More with Mass PhotometryUnlocking the Benefits of Mass Measurement: Transforming Analytical Workflows for Antibodies, Nucleic Acids, and More with Mass Photometry

bySalma Jalal
Aug 19, 2024
Mycotoxin Risk Determination: Measuring the Potential for Patient Exposure with Antithrombin Alfa Sourced from Transgenic Goat Milk
Bioanalytical Methods
Mycotoxin Risk Determination: Measuring the Potential for Patient Exposure with Antithrombin Alfa Sourced from Transgenic Goat MilkMycotoxin Risk Determination: Measuring the Potential for Patient Exposure with Antithrombin Alfa Sourced from Transgenic Goat Milk
byGreg Allard, Sean Evans
Mar 16, 2022
Risk Determination of Potential Mycotoxin Exposure to Patients: Testing Recombinant Human Factor VII from Transgenic Rabbits
Bioanalytical Methods
Risk Determination of Potential Mycotoxin Exposure to Patients: Testing Recombinant Human Factor VII from Transgenic RabbitsRisk Determination of Potential Mycotoxin Exposure to Patients: Testing Recombinant Human Factor VII from Transgenic Rabbits
byGreg Allard, Nick Masielloand 2 more
Oct 28, 2021
Emerging Tools for Exosome Purification and In-Process Monitoring
Bioanalytical Methods
Emerging Tools for Exosome Purification and In-Process MonitoringEmerging Tools for Exosome Purification and In-Process Monitoring
byKatja Vrabec, Tjaša Lojpurand 1 more
Mar 22, 2019
eBook: Development of a Representative Scale-Down UF/DF Model: Overcoming Equipment Limitations and Associated Process Challenges
Bioanalytical Methods
eBook: Development of a Representative Scale-Down UF/DF Model: Overcoming Equipment Limitations and Associated Process ChallengeseBook: Development of a Representative Scale-Down UF/DF Model: Overcoming Equipment Limitations and Associated Process Challenges
byLawrence Huang, Zachary Rogersand 1 more
Feb 28, 2018
Clearance of Persistent Small-Molecule Impurities: Alternative Strategies
Bioanalytical Methods
Clearance of Persistent Small-Molecule Impurities: Alternative StrategiesClearance of Persistent Small-Molecule Impurities: Alternative Strategies
byAlan K. Hunter, Andrew Fultonand 2 more
May 11, 2016
Detecting the Broad Spectrum of Pyrogens with the Human Whole-Blood Monocyte Activation Test
Bioanalytical Methods
Detecting the Broad Spectrum of Pyrogens with the Human Whole-Blood Monocyte Activation Test
Detecting the Broad Spectrum of Pyrogens with the Human Whole-Blood Monocyte Activation Test
Mar 11, 2016
+1
byThomas Hartung, Audrey Boreland 1 more
Defining Your Product Profile and Maintaining Control Over It | A Look Back with Emily Shacter
Bioanalytical Methods
Defining Your Product Profile and Maintaining Control Over It | A Look Back with Emily Shacter
Defining Your Product Profile and Maintaining Control Over It | A Look Back with Emily Shacter
Feb 11, 2016
byLeah Rosin
Development of a Novel Host-Cell Protein Assay: Supporting the <i>Physcomitrella patens</i> Expression System
Bioanalytical Methods
Development of a Novel Host-Cell Protein Assay: Supporting the Physcomitrella patens Expression System
Development of a Novel Host-Cell Protein Assay: Supporting the Physcomitrella patens Expression System
Feb 4, 2016
+4
byPaulina Dabrowska-Schlepp, Stefan Sommerschuhand 4 more
Evaluation of a Variable-Pathlength Spectrophotometer: A Comparable Instrument for Determining Protein Concentration
Bioanalytical Methods
Evaluation of a Variable-Pathlength Spectrophotometer: A Comparable Instrument for Determining Protein Concentration
Evaluation of a Variable-Pathlength Spectrophotometer: A Comparable Instrument for Determining Protein Concentration
Jun 16, 2015
+2
byBriana Lehr, John Robinsonand 2 more
Hamster Phospholipase B-Like 2 (PLBL2): A Host-Cell Protein Impurity in Therapeutic Monoclonal Antibodies Derived from Chinese Hamster Ovary Cells
Bioanalytical Methods
Hamster Phospholipase B-Like 2 (PLBL2): A Host-Cell Protein Impurity in Therapeutic Monoclonal Antibodies Derived from Chinese Hamster Ovary Cells
Hamster Phospholipase B-Like 2 (PLBL2): A Host-Cell Protein Impurity in Therapeutic Monoclonal Antibodies Derived from Chinese Hamster Ovary Cells
Apr 14, 2015
+21
byMartin Vanderlaan, Wendy Sandovaland 21 more
Unwanted Immunogenicity: From Risk Assessment to Risk Management
Bioanalytical Methods
Unwanted Immunogenicity: From Risk Assessment to Risk Management
Unwanted Immunogenicity: From Risk Assessment to Risk Management
Nov 10, 2014
byCheryl Scott
Understanding and Controlling Sources of Process Variation: Risks to Achieving Product Critical Quality Attributes
Bioanalytical Methods
Understanding and Controlling Sources of Process Variation: Risks to Achieving Product Critical Quality Attributes
Understanding and Controlling Sources of Process Variation: Risks to Achieving Product Critical Quality Attributes
Oct 16, 2014
byNick Hutchinson
Prior-Knowledge Assessments logo in a gray background | Prior-Knowledge Assessments
Bioanalytical Methods
Prior-Knowledge Assessments
Prior-Knowledge Assessments
Oct 1, 2012
byJames E. Seely, Roger A. Hart
Host Cellular Protein Quantification logo in a gray background | Host Cellular Protein Quantification
Bioanalytical Methods
Host Cellular Protein Quantification
Host Cellular Protein Quantification
Feb 1, 2012
+2
byNan Liu, Maxim Brevnovand 2 more
How QbD and the FDA Process Validation Guidance Affect Product Development and Operations, Part 1 logo in a gray background | How QbD and the FDA Process Validation Guidance Affect Product Development and Operations, Part 1
Bioanalytical Methods
How QbD and the FDA Process Validation Guidance Affect Product Development and Operations, Part 1
How QbD and the FDA Process Validation Guidance Affect Product Development and Operations, Part 1
Nov 1, 2011
byPeter H. Calcott
Implementation of the ASTM Standard for Manufacturing Systems Verification logo in a gray background | Implementation of the ASTM Standard for Manufacturing Systems Verification
Bioanalytical Methods
Implementation of the ASTM Standard for Manufacturing Systems Verification
Implementation of the ASTM Standard for Manufacturing Systems Verification
Sep 1, 2011
byPeter Watler
<p> Top 10 Changes in FDA's Process Validation Guidance </p> logo in a gray background | <p> Top 10 Changes in FDA's Process Validation Guidance </p>
Bioanalytical Methods
Top 10 Changes in FDA's Process Validation Guidance
Top 10 Changes in FDA's Process Validation Guidance
Jun 1, 2011
byPeter K. Watler
Validation of Intermediate Hold Times logo in a gray background | Validation of Intermediate Hold Times
Bioanalytical Methods
Validation of Intermediate Hold Times
Validation of Intermediate Hold Times
Apr 1, 2011
byPiranavan Thillaivinayagalingam, Anthony R. Newcombe
<p> Distinctions Between <i>Analytical</i> and <i>Bioanalytical</i> Test Methods </p> logo in a gray background | <p> Distinctions Between <i>Analytical</i> and <i>Bioanalytical</i> Test Methods </p>
Bioanalytical Methods
Distinctions Between Analytical and Bioanalytical Test Methods
Distinctions Between Analytical and Bioanalytical Test Methods
Mar 1, 2011
byNadine M. Ritter
Microanalytical Techniques for Identifying Nonprotein Contaminants in Biologics logo in a gray background | Microanalytical Techniques for Identifying Nonprotein Contaminants in Biologics
Bioanalytical Methods
Microanalytical Techniques for Identifying Nonprotein Contaminants in Biologics
Microanalytical Techniques for Identifying Nonprotein Contaminants in Biologics
Feb 1, 2010
byMary Stellmack
A Modular Approach to Facility Validation logo in a gray background | A Modular Approach to Facility Validation
Bioanalytical Methods
A Modular Approach to Facility Validation
A Modular Approach to Facility Validation
Nov 1, 2009
byBPI Contributor
New Validation Guidance Causes a Stir logo in a gray background | New Validation Guidance Causes a Stir
Bioanalytical Methods
New Validation Guidance Causes a Stir
New Validation Guidance Causes a Stir
Jun 1, 2009
byBPI Contributor
Encyclopedia of Rapid Microbiological Methods logo in a gray background | Encyclopedia of Rapid Microbiological Methods
Bioanalytical Methods
Encyclopedia of Rapid Microbiological Methods
Encyclopedia of Rapid Microbiological Methods
Apr 1, 2009
byMareike Viebahn
Robustness of Parvovirus–Retentive Membranes and Implications for Virus Clearance Validation Requirements logo in a gray background | Robustness of Parvovirus–Retentive Membranes and Implications for Virus Clearance Validation Requirements
Bioanalytical Methods
Robustness of Parvovirus–Retentive Membranes and Implications for Virus Clearance Validation Requirements
Robustness of Parvovirus–Retentive Membranes and Implications for Virus Clearance Validation Requirements
Feb 1, 2009
+4
byPascal Valax, Elodie Charbautand 4 more
Managing the Analytical Life-Cycle for Biotechnology Products logo in a gray background | Managing the Analytical Life-Cycle for Biotechnology Products
Bioanalytical Methods
Managing the Analytical Life-Cycle for Biotechnology Products
Managing the Analytical Life-Cycle for Biotechnology Products
Oct 1, 2008
byIzydor Apostol, Drew Kelner
Managing the Analytical Lifecycle for Biotechnology Products logo in a gray background | Managing the Analytical Lifecycle for Biotechnology Products
Bioanalytical Methods
Managing the Analytical Lifecycle for Biotechnology Products
Managing the Analytical Lifecycle for Biotechnology Products
Sep 1, 2008
byIzydor Apostol, Drew N. Kelner
Reducing Microbial Contamination Risk in Biotherapeutic Manufacturing logo in a gray background | Reducing Microbial Contamination Risk in Biotherapeutic Manufacturing
Bioanalytical Methods
Reducing Microbial Contamination Risk in Biotherapeutic Manufacturing
Reducing Microbial Contamination Risk in Biotherapeutic Manufacturing
Sep 1, 2008
byBPI Contributor
Biotech Facilities Average a Batch Failure Every 40.6 Weeks logo in a gray background | Biotech Facilities Average a Batch Failure Every 40.6 Weeks
Bioanalytical Methods
Biotech Facilities Average a Batch Failure Every 40.6 Weeks
Biotech Facilities Average a Batch Failure Every 40.6 Weeks
Sep 1, 2008
byEric S. Langer
Secrets to a Successful Validation Project logo in a gray background | Secrets to a Successful Validation Project
Bioanalytical Methods
Secrets to a Successful Validation Project
Secrets to a Successful Validation Project
May 1, 2008
byRey Hernandez, Judith Echevarria
Elevating Standard ELISA Technology By Sterilizing Pipet Tips with "Cold" Atmospheric Plasma logo in a gray background | Elevating Standard ELISA Technology By Sterilizing Pipet Tips with "Cold" Atmospheric Plasma
Bioanalytical Methods
Elevating Standard ELISA Technology By Sterilizing Pipet Tips with "Cold" Atmospheric Plasma
Elevating Standard ELISA Technology By Sterilizing Pipet Tips with "Cold" Atmospheric Plasma
Oct 1, 2007
byBPI Contributor
The Basics of Cleaning and Cleaning Validation logo in a gray background | The Basics of Cleaning and Cleaning Validation
Bioanalytical Methods
The Basics of Cleaning and Cleaning Validation
The Basics of Cleaning and Cleaning Validation
Jun 1, 2007
byBPI Contributor
High-Throughput Glycoanalysis for Biopharmaceutical Development and Manufacturing logo in a gray background | High-Throughput Glycoanalysis for Biopharmaceutical Development and Manufacturing
Bioanalytical Methods
High-Throughput Glycoanalysis for Biopharmaceutical Development and Manufacturing
High-Throughput Glycoanalysis for Biopharmaceutical Development and Manufacturing
Feb 1, 2007
byBPI Contributor
Analytical Technology and PAT logo in a gray background | Analytical Technology and PAT
Bioanalytical Methods
Analytical Technology and PAT
Analytical Technology and PAT
Jan 1, 2007
byBPI Contributor
In Situ Monitoring of CHO Cell Culture Medium Using Near-Infrared Spectroscopy logo in a gray background | In Situ Monitoring of CHO Cell Culture Medium Using Near-Infrared Spectroscopy
Bioanalytical Methods
In Situ Monitoring of CHO Cell Culture Medium Using Near-Infrared Spectroscopy
In Situ Monitoring of CHO Cell Culture Medium Using Near-Infrared Spectroscopy
Jan 1, 2007
byBPI Contributor

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Ask the Expert webcasts
ATE Webcasts
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Ask the Expert webcasts
ATE Webcasts
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Emerson white paper
Sponsored Content
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency

Nov 12, 2024

WuXi Bio white paper
Sponsored Content
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products

Nov 8, 2024

Bora white paper
Sponsored Content
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages

Nov 8, 2024